T2DM mice treated with ginseng polypeptide (GP) on a high-sugar and high-fat diet (including streptozotocin (STZ)) showed that GP could play a hypoglycemic role by restoring the SCFA-producing microbiota in the intestine, and enriched the microflora closely related to lipid metabolism, oxidative stress and inflammatory response, such as desalted bacilli, Bifidobacterium spp., and bacteroides (128)
100% Daily Value of Vitamin D3 Each serving provides 100% Daily Value of Vitamin D3 (as vegan cholecalciferol), supporting both immune health and gut microbiome balance
optimal choice depends on efficacy, safety, access, patient preferences, and your behavioral support system
Clinical Evidence on Post-Ozempic Weight Rebound Rates The STEP trials, which established Ozempic's efficacy for weight loss, also documented rebound patterns after discontinuation

useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established